Diligence memo · auto-generated · as of July 2, 2026
Nevoa Life Sciences Holdings, Inc.
Nevoa Life Sciences Holdings, Inc. looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Nevoa Life Sciences Holdings, Inc. operates in Other, based in GILBERT.
Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Nevoa Life Sciences Holdings, Inc. has raised $16M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.2M on 2022-01-01.
Most recent recorded round closed around 2024-12-19.
Valuation (modeled)modeled
Provath models Nevoa Life Sciences Holdings, Inc. at approximately $23M (range $8.0M–$45M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.60× the median modeled value of Series A Other companies in 2022–2024 (1135 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 18 mo ago; this sector typically re-raises about every 11 months.
Slightly overdue versus sector cadence.
The last round was 1.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 83% of Other peers (25015 compared).
Modeled value ranks above 58% of those peers.
Closest niche peers: Ness Well, Inc., Quantori, Inc., Qquv Investments 5, Llc, Applause Network TV, Inc., Trustworthy Co.
Peoplefiled
17 named people on file across officers, directors and signatories.
Risks & flagsmixed
Broad sector classification weakens peer comparison.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.